AYALA HEALTHCARE Holdings, Inc. (AC Health) has entered a partnership with Sanofi Philippines to provide Filipinos with better healthcare treatment, especially for those with lifestyle diseases.

The collaboration aims to better support lifestyle disease patients with diabetes and hypertension with their health maintenance through education and providing accessible healthcare solutions.

“I am delighted that we are now working with Sanofi for healthcare, a sector that we believe would be a key driver of growth to the Ayala Group,” Ayala Corporation President and Chief Operating Officer Fernando Zobel de Ayala said at the memorandum signing on Tuesday.

Mr. Zobel said the coronavirus disease 2019 (COVID-19) pandemic further strengthened the conglomerate’s commitment to healthcare.

“If there is one thing that we have learned in this pandemic, it has been the power of collaboration between the government, the private sector, and specifically the many healthcare companies and institutions that have been at the forefront of this pandemic,” he added.

Sanofi also aims to improve primary care capacity-building, to educate patients more, and to make healthcare solutions more accessible.

“Together with AC Health, we are both united on our mission to provide Filipinos living with chronic diseases such as diabetes and hypertension with the personalized care they deserve. We believe that health is for all,” country lead for Sanofi Philippines and General Manager for Sanofi General Medicines Dr. Amal Makhloufi said at the conference.

“By bringing together our combined network of clinics and hospitals, and Sanofi’s pharmaceutical expertise, I am confident we can improve access to chronic care across multiple touchpoints and even in the digital space. I am equally excited about working with Sanofi, to provide continuing education to our doctors and healthcare workers,” AC Health President and Chief Executive Officer Paolo Maximo F. Borromeo said. — Keren Concepcion G. Valmonte